[骨髓瘤中长非编码RNA DLEU1 的预后价值和机制]
Jing-Jing Zhang1, Ping Yang1, Xiao-Qiang Shang1
1Department of Orthopedics, Union Wuhan Red Cross Hospital, Wuhan 430015, Hubei, China.
概括
长非编码RNA DLEU1 (LncRNA DLEU1) 的高表达与更好的骨髓瘤预后有关. 低调的LncRNA DLEU1抑制癌细胞入侵,表明其作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 骨髓瘤是一种具有可变预后的原发性骨恶性瘤.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在癌症发育和进展中的作用.
- 在骨髓瘤中LncRNA DLEU1的特定作用尚未完全阐明.
研究的目的:
- 为了研究LncRNA DLEU1在骨髓瘤中的预后价值.
- 探索LncRNA DLEU1在骨髓瘤进展中的潜在机制.
主要方法:
- 对86名骨质肉瘤患者样本和临床数据的回顾性分析.
- 定量实时PCR (qRT-PCR) 用于评估LncRNA DLEU1表达水平.
- 与临床病理因素的相关性分析,生存分析 (卡普兰-梅尔,考克斯回归) 和体外细胞入侵试验 (Transwell).
主要成果:
- 与正常对照组相比,LncRNA DLEU1表达在骨髓瘤组织和细胞系中显著升高.
- 高LncRNA DLEU1表达与先进的 Enneking 阶段,远程转移和更高的组织学等级相关.
- 具有高LncRNA DLEU1表达的患者显示出明显更好的1年和5年整体存活率. LncRNA DLEU1被确定为预后不佳的独立风险因素. 对LncRNA DLEU1的降低调节减少了骨髓瘤细胞入侵.
结论:
- 高LncRNA DLEU1表达作为一个重要的分子标志物用于骨髓瘤患者的良好预后.
- LncRNA DLEU1 在促进骨髓瘤细胞入侵方面发挥作用.
- 准LncRNA DLEU1可能为骨髓瘤提供一种潜在的治疗策略.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
03:18Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K